Logo image of IHRT

IHEARTMEDIA INC - CLASS A (IHRT) Stock Fundamental Analysis

NASDAQ:IHRT - Nasdaq - US45174J5092 - Common Stock - Currency: USD

2.11  -0.07 (-3.21%)

After market: 2.19 +0.08 (+3.79%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to IHRT. IHRT was compared to 93 industry peers in the Media industry. IHRT has a bad profitability rating. Also its financial health evaluation is rather negative. IHRT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year IHRT has reported negative net income.
In the past year IHRT had a positive cash flow from operations.
In the past 5 years IHRT reported 4 times negative net income.
Each year in the past 5 years IHRT had a positive operating cash flow.
IHRT Yearly Net Income VS EBIT VS OCF VS FCFIHRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B 8B 10B

1.2 Ratios

With a Return On Assets value of -17.79%, IHRT is not doing good in the industry: 82.76% of the companies in the same industry are doing better.
IHRT has a Return On Invested Capital (2.12%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for IHRT is below the industry average of 7.01%.
Industry RankSector Rank
ROA -17.79%
ROE N/A
ROIC 2.12%
ROA(3y)-6.94%
ROA(5y)12.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)2.71%
ROIC(5y)2.54%
IHRT Yearly ROA, ROE, ROICIHRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 200 300

1.3 Margins

With a Operating Margin value of 3.53%, IHRT perfoms like the industry average, outperforming 40.23% of the companies in the same industry.
In the last couple of years the Operating Margin of IHRT has declined.
IHRT has a better Gross Margin (59.30%) than 70.11% of its industry peers.
In the last couple of years the Gross Margin of IHRT has declined.
Industry RankSector Rank
OM 3.53%
PM (TTM) N/A
GM 59.3%
OM growth 3Y378.98%
OM growth 5Y-25.91%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.21%
GM growth 5Y-3.14%
IHRT Yearly Profit, Operating, Gross MarginsIHRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 200 300

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IHRT is destroying value.
The number of shares outstanding for IHRT has been increased compared to 1 year ago.
The number of shares outstanding for IHRT has been increased compared to 5 years ago.
IHRT has a worse debt/assets ratio than last year.
IHRT Yearly Shares OutstandingIHRT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M
IHRT Yearly Total Debt VS Total AssetsIHRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of -0.15, we must say that IHRT is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.15, IHRT is not doing good in the industry: 80.46% of the companies in the same industry are doing better.
The Debt to FCF ratio of IHRT is 37.32, which is on the high side as it means it would take IHRT, 37.32 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 37.32, IHRT is doing worse than 63.22% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 37.32
Altman-Z -0.15
ROIC/WACC0.33
WACC6.4%
IHRT Yearly LT Debt VS Equity VS FCFIHRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10B -10B 20B

2.3 Liquidity

IHRT has a Current Ratio of 1.93. This is a normal value and indicates that IHRT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.93, IHRT is in the better half of the industry, outperforming 62.07% of the companies in the same industry.
A Quick Ratio of 1.93 indicates that IHRT should not have too much problems paying its short term obligations.
IHRT's Quick ratio of 1.93 is fine compared to the rest of the industry. IHRT outperforms 62.07% of its industry peers.
Industry RankSector Rank
Current Ratio 1.93
Quick Ratio 1.93
IHRT Yearly Current Assets VS Current LiabilitesIHRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 1.15% over the past year.
IHRT shows a decrease in Revenue. In the last year, the revenue decreased by -0.19%.
The Revenue has been growing slightly by 0.76% on average over the past years.
EPS 1Y (TTM)1.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-350%
Revenue 1Y (TTM)-0.19%
Revenue growth 3Y8.36%
Revenue growth 5Y0.76%
Sales Q2Q%5.79%

3.2 Future

IHRT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.81% yearly.
IHRT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.42% yearly.
EPS Next Y11.2%
EPS Next 2Y40.44%
EPS Next 3Y27.81%
EPS Next 5YN/A
Revenue Next Year4.76%
Revenue Next 2Y1.98%
Revenue Next 3Y2.97%
Revenue Next 5Y4.42%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IHRT Yearly Revenue VS EstimatesIHRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
IHRT Yearly EPS VS EstimatesIHRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -5 -10

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IHRT. In the last year negative earnings were reported.
Also next year IHRT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IHRT Price Earnings VS Forward Price EarningsIHRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

IHRT's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, IHRT is valued cheaper than 93.10% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.22
EV/EBITDA 9.28
IHRT Per share dataIHRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20

4.3 Compensation for Growth

A more expensive valuation may be justified as IHRT's earnings are expected to grow with 27.81% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.44%
EPS Next 3Y27.81%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IHRT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IHEARTMEDIA INC - CLASS A

NASDAQ:IHRT (2/21/2025, 8:27:54 PM)

After market: 2.19 +0.08 (+3.79%)

2.11

-0.07 (-3.21%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)02-27 2025-02-27/amc
Inst Owners87.09%
Inst Owner Change2.45%
Ins Owners4.38%
Ins Owner Change-0.1%
Market Cap310.32M
Analysts52
Price Target3.65 (72.99%)
Short Float %5.37%
Short Ratio8.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1550.65%
Min EPS beat(2)-1942.48%
Max EPS beat(2)-1158.82%
EPS beat(4)1
Avg EPS beat(4)-771.37%
Min EPS beat(4)-1942.48%
Max EPS beat(4)79.07%
EPS beat(8)2
Avg EPS beat(8)-766.49%
EPS beat(12)4
Avg EPS beat(12)-595.67%
EPS beat(16)4
Avg EPS beat(16)-478.24%
Revenue beat(2)0
Avg Revenue beat(2)-0.91%
Min Revenue beat(2)-1.26%
Max Revenue beat(2)-0.56%
Revenue beat(4)1
Avg Revenue beat(4)-1.06%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)0.36%
Revenue beat(8)1
Avg Revenue beat(8)-0.68%
Revenue beat(12)2
Avg Revenue beat(12)-0.76%
Revenue beat(16)5
Avg Revenue beat(16)-0.17%
PT rev (1m)0%
PT rev (3m)114.99%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-23.87%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.34%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.08
P/FCF 2.22
P/OCF 1.38
P/B N/A
P/tB N/A
EV/EBITDA 9.28
EPS(TTM)-6.88
EYN/A
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)0.95
FCFY45.09%
OCF(TTM)1.52
OCFY72.27%
SpS25.86
BVpS-9.62
TBVpS-29.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.79%
ROE N/A
ROCE 2.69%
ROIC 2.12%
ROICexc 2.32%
ROICexgc 6.38%
OM 3.53%
PM (TTM) N/A
GM 59.3%
FCFM 3.68%
ROA(3y)-6.94%
ROA(5y)12.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)2.71%
ROIC(5y)2.54%
ROICexc(3y)2.85%
ROICexc(5y)2.66%
ROICexgc(3y)10.39%
ROICexgc(5y)10.59%
ROCE(3y)3.43%
ROCE(5y)3.22%
ROICexcg growth 3Y435.68%
ROICexcg growth 5Y-8.76%
ROICexc growth 3Y473.4%
ROICexc growth 5Y-15.34%
OM growth 3Y378.98%
OM growth 5Y-25.91%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.21%
GM growth 5Y-3.14%
F-Score4
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 37.32
Debt/EBITDA 9.48
Cap/Depr 20.26%
Cap/Sales 2.22%
Interest Coverage 0.34
Cash Conversion 40.73%
Profit Quality N/A
Current Ratio 1.93
Quick Ratio 1.93
Altman-Z -0.15
F-Score4
WACC6.4%
ROIC/WACC0.33
Cap/Depr(3y)33.05%
Cap/Depr(5y)31.48%
Cap/Sales(3y)4%
Cap/Sales(5y)3.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-350%
EPS Next Y11.2%
EPS Next 2Y40.44%
EPS Next 3Y27.81%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.19%
Revenue growth 3Y8.36%
Revenue growth 5Y0.76%
Sales Q2Q%5.79%
Revenue Next Year4.76%
Revenue Next 2Y1.98%
Revenue Next 3Y2.97%
Revenue Next 5Y4.42%
EBIT growth 1Y-48.56%
EBIT growth 3Y419.02%
EBIT growth 5Y-25.34%
EBIT Next Year196.66%
EBIT Next 3Y46.42%
EBIT Next 5Y28.1%
FCF growth 1Y-4.15%
FCF growth 3Y-5.47%
FCF growth 5Y-30.29%
OCF growth 1Y-34.17%
OCF growth 3Y-0.44%
OCF growth 5Y-26.1%